Enhertu (Trastuzumab Deruxtecan)) approved in the US for HER2-positive unresectable or metastatic breast cancer following two or more prior anti-HER2 based regimens.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Enhertu (Trastuzumab Deruxtecan) injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Enhertu (Trastuzumab Deruxtecan) injection medicine cost price in India.
The order for Enhertu Trastuzumab Deruxtecan injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Trastuzumab deruxtecan also known as fam-trastuzumab deruxtecan and sold under the brand name Enhertu, is a medication used for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting.
Enhertu (Trastuzumab Deruxtecan) injection for oral administration Initial U.S. Approval: 2009
Generic Name: Trastuzumab Deruxtecan
For injection: 100 mg lyophilized powder in a single-dose vial
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand pemnat (Pemetrexed) Injection on prescription and Import License in Patient's Name only.
For overseas patients, pemnat (Pemetrexed) Injection can be made available in Send your enquiry to find pemnat (Pemetrexed) Injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Enhertu (Trastuzumab Deruxtecan) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update. For More Details
FDA Approves Generic Trastuzumab Deruxtecan injection For More Details